Meditrina secures FDA clearance for Gen 2 hysteroscopy system
The bipolar RF technology of the new system enables more controlled tissue removal with haemostasis. Credit: Svitlana Hulko/Shutterstock.com. Meditrina has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its Gen 2 bipolar radio-frequency (RF) hysteroscopy system and Aveta Glo bipolar RF device. This clearance marks a significant milestone in the advancement […]
Boston Scientific hits all endpoints in CRM trial
The Boston Scientific device consists of an Emblem subcutaneous implantable defibrillator system and Empower leadless pacemaker. Credit: Shutterstock / jeffy11390. Boston Scientific has announced six-month positive results from its ongoing pivotal MODULAR ATP clinical trial examining the company’s modular cardiac rhythm management (mCRM) technology. The findings published in the New England Journal of Medicine detail […]
Dexcom launches upgraded ONE+ device in UK
Dexcom has launched the upgraded ONE+ continuous glucose monitoring (CGM) device in the UK. Credit: Around the World Photos via Shutterstock. Dexcom has launched its ONE+ continuous glucose monitoring (CGM) device in the UK, alongside a report that details high rates of anxiety and depression amongst type 2 diabetes (T2D) patients. The Dexcom ONE+ device […]
Morgan Scientific partners with ZEPHYRx for respiratory care
The integration offers healthcare providers comprehensive insights into patients’ lung health. Credit: Golden Dayz/Shutterstock.com. Morgan Scientific has partnered with ZEPHYRx, a digital health technology innovator, to advance respiratory care. The collaboration aims to advance respiratory care by integrating ZEPHYRx’s remote spirometry platform with Morgan Scientific’s ComPAS2 pulmonary function test (PFT) software. This allows healthcare providers […]
FDA issues 510(k) clearance for Implicity’s SignalHF1 algorithm
The Implicity’s algorithm can identify trends that signal a deterioration in a patient’s condition. Credit: Implicity. The US Food and Drug Administration (FDA) has issued 510(k) approval to Implicity’s heart failure prediction algorithm, SignalHF1, designed to work with its remote monitoring solution. Implicity is said to have leveraged one of the world’s largest heart disease […]
Management of cardiovascular conditions: Smart pacemakers
Cardiovascular health management is getting smarter, from artificial intelligence (AI) use for early disease detection to remote and real-time cardiac care. In 2022, almost 1.5 million people around the world received a pacemaker, and GlobalData forecasts that this will rise to 2.5 million by 2033 [1]. Recent advances in smart pacemaker technologies are driving significant improvements in cardiac care, […]
OncoHost on liquid biopsy, AI, and developing Israel’s life sciences ecosystem
Startups in Israel focused on liquid biopsy receive support from the Israel Innovation Authority (IIA). Credit: Billion Photos / Shutterstock Liquid biopsy technology is advancing, but investors remain sceptical. Startups across Israel are developing liquid biopsy tests, and the quest for investment is growing ever more competitive. As a result, the need for companies in […]
Trinity partners with PulseAI to develop CGM sensor technology
GlobalData expects the CGM device market to generate $8.4bn in 2030. Image Credit: Halfpoint / Shutterstock. Irish diagnostics and diabetes management company Trinity Biotech has partnered with an Irish medical artificial intelligence (AI) company PulseAI to enhance its continuous glucose monitor (CGM) biosensor technology. Trinity added the CGM technology to its portfolio as part of […]
Brainomix swings FDA clearance for its lung imaging AI software
The FDA clearance follows after a phase II tralokinumab clinical trial published in the American Journal of Respiratory and Critical Care Medicine. Credit: Shutterstock / Gorodenkoff UK-based artificial intelligence (AI) company, Brainomix, has seen its 360 e-Lung system granted market clearance from the US Food and Drug Administration (FDA) off the back of a study […]
Caresyntax gears up to grow digital surgery platform
Image credit: Shutterstock/PopTika A $15 million investment from Swiss venture capital firm MTIP AG is tipped to accelerate the commercial growth and expansion of Caresyntax’s data-driven surgery platform. MTIP’s eighth investment in the company closed out Caresyntax’s Series C funding, which raised a total of $130 million from a large number of major international investors. […]